MariMed Inc. (MRMD)
OTCMKTS
· Delayed Price · Currency is USD
0.0708
-0.0003 (-0.42%)
Jun 13, 2025, 3:45 PM EDT
MariMed Revenue
MariMed had revenue of $37.96M in the quarter ending March 31, 2025, with 0.06% growth. This brings the company's revenue in the last twelve months to $157.99M, up 3.84% year-over-year. In the year 2024, MariMed had annual revenue of $157.96M with 6.30% growth.
Revenue (ttm)
157.99M
Revenue Growth
+3.84%
P/S Ratio
0.18
Revenue / Employee
204.12K
Employees
832
Market Cap
28.32M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
MariMed News
- 16 days ago - Cannabis Stock Gainers And Losers From May 29, 2025 - Benzinga
- 16 days ago - MariMed's Premium Nature's Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDose - GlobeNewsWire
- 18 days ago - Cannabis Stock Movers For May 27, 2025 - Benzinga
- 5 weeks ago - MariMed Inc. (MRMD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Cannabis Earnings Show Market Split: US Plant-Touching Stocks Drop, IIPR And Cronos Up - Benzinga
- 5 weeks ago - MariMed Reports First Quarter 2025 Earnings - GlobeNewsWire
- 5 weeks ago - MariMed Q1 2025 Earnings Preview - Seeking Alpha
- 2 months ago - Cannabis Stock Gainers And Losers From April 14, 2025 - Benzinga